FDA Director Updates Congress on its Medical Device Reform Efforts
In testimony before Congress on April 13, 2011, the FDA's Director for Medical Devices, Dr. William Maisel, discussed the agency's efforts to reform the medical device programs, including the FDA's 510(k) action plan for these products, its Medical Device Innovation…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
Initiative, post market surveillance activities, adverse event reporting, and device recall improvements, among other activities.